

























































published: 06 May 2013
doi: 10.3389/fimmu.2013.00103
Interaction of the capsular polysaccharide A from
Bacteroides fragilis with DC-SIGN on human dendritic cells
is necessary for its processing and presentation toT cells
Karien Bloem1,2, Juan J. García-Vallejo1, Ilona M.Vuist 1, Brian A. Cobb3, Sandra J. vanVliet 1 and
Yvette van Kooyk 1*
1 Department of Molecular Cell Biology and Immunology, VU University Medical Center, Amsterdam, Netherlands
2 Centre for Specialized Nutrition, Danone Research,Wageningen, Netherlands
3 Department of Pathology, CaseWestern Reserve University School of Medicine, Cleveland, OH, USA
Edited by:
Paul A. Ramsland, Burnet Institute,
Australia
Reviewed by:
Meredith O’Keeffe, Burnet Institute
for Medical Research, Australia
Mihaela Gadjeva, Harvard Medical
School, USA
*Correspondence:
Yvette van Kooyk, Department of
Molecular Cell Biology and
Immunology, VU University Medical
Center, P. O. Box 7057, Van der
Boechorststraat 7, 1007 MB
Amsterdam, Netherlands.
e-mail: y.vankooyk@vumc.nl
The zwitterionic capsular polysaccharide A (PSA) of Bacteroides fragilis is the first
carbohydrate antigen described to be presented in major histocompatibility complex (MHC)
class II for the induction of CD4+ T cell responses. However, the identity of the receptor
mediating binding and internalization of PSA in antigen presenting cells remains elusive.
C-type lectins are glycan-binding receptors known for their capacity to target ligands for
antigen presentation toT cells. Here, we investigated whether C-type lectins were involved
in the internalization of PSA and identified dendritic cell-specific intercellular adhesion
molecule-3-grabbing non-integrin (DC-SIGN) as the main receptor for PSA on human den-
dritic cells (DC).The induction of PSA-specificT cell proliferation appeared to be completely
dependent on DC-SIGN. These data reveal a crucial role for DC-SIGN in the endocytosis
and routing of PSA in human DC for the efficient stimulation of PSA-specific CD4+ T cells.
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INTRODUCTION
In the defense against infection, specialized antigen presenting
cells (APCs), such as dendritic cells (DCs) are able to endocy-
tose pathogens into acidic compartments rich in endoproteases
to allow the processing required for the extraction of antigenic
epitopes. These peptide epitopes are then loaded onto major his-
tocompatibility complex (MHC) class II and presented to CD4+
T cells. Until recently, peptides originating from the enzymatic
degradation of protein antigens were thought to be the only class
of molecules capable of being presented in MHC class II. However,
these peptides can be posttranslationally modified with glycans, as
has been shown for the MHC class II presentation of glycopeptides
derived from the tumor antigen MUC1 (Vlad et al., 2002) or type
II collagen (Michaëlsson et al., 1994).
Although DCs are able to endocytose different types of glyco-
conjugates and some of these glycoconjugates facilitate the induc-
tion of essential T cell help leading to the efficient production of
glycan-specific antibodies (Astronomo and Burton, 2010); it was
not until recently that the direct presentation of a polysaccha-
ride on MHC class II was described. Zwitterionic polysaccharides
(ZPSs) purified from the capsule of different bacteria were shown
to activate CD4+ T cell responses without prior conjugation
to a peptide (Tzianabos et al., 2000a,b). ZPSs are composed of
repeating carbohydrate units in a polysaccharide structure, which
contain both negatively and positively charged motifs, causing the
formation of a helical structure (Choi et al., 2002), thereby resem-
bling the structure of peptides in MHC class II. Removal of the
positive charge in the ZPS of B. fragilis, polysaccharide A (PSA),
led to the inability to fit into the MHC class II groove and thus
failure to activate T cells. Strikingly, removal of the positive charge
does not alter endocytosis, demonstrating that PSA is internalized
independently of the charge of the molecule (Cobb and Kasper,
2008).
Protein antigens are normally processed by endoproteases in
acidic compartments within the endo-lysosomal pathway. The
short peptides generated are then loaded predominantly on MHC
class II for presentation to CD4+ T cells. PSA also needs to be
processed before it can be presented on MHC class II. We have
previously shown that cleavage of PSA is a non-enzymatic oxida-
tive reaction facilitated by the production of nitric oxide (NO) by
inducible NO synthase (iNOS, EC.1.12.13.39), resulting in glycan
structures of approximately 15 repeating units (Cobb et al., 2004).
Furthermore, the formation of abscesses was completely absent in
iNOS−/− mice challenged with PSA or live B. fragilis, indicating
that the iNOS-dependent degradation of PSA is a necessary event
for presentation of PSA to T cells.
The mechanism of PSA internalization by DCs in order to
enter the endo-lysosomal pathway for MHC class II presentation
has remained unresolved until now. We suspected that since the
internalization of PSA is a receptor-mediated event (Cobb et al.,
2004) and DCs are equipped with a wide variety of antigen-uptake
receptors including several C-type lectin receptors (CLRs) with
specificity for glycans, CLRs would be likely candidates for the
endocytosis of PSA. In addition, CLRs can target their ligands to
the endo-lysosomal pathway for MHC class II presentation (van
Vliet et al., 2008) and could therefore route PSA to MHC class
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II loading compartments. We here show that PSA is a ligand for
the CLR dendritic cell-specific intercellular adhesion molecule-3-
grabbing non-integrin (DC-SIGN) and that blocking DC-SIGN
on DCs resulted in inhibition of PSA-specific T cell proliferation.
MATERIALS AND METHODS
Fc CHIMERIC PROTEINS AND ANTIBODIES
DC-SIGN-Fc is composed of the extracellular domains of DC-
SIGN (amino acid residues 64–404) fused to the Fc domain of
human IgG1 (Geijtenbeek et al., 2002). DC-SIGN-Fc was pro-
duced in CHO cells and purified with a Hi Trap Protein A HP
column (GE Healthcare). The following antibodies were used: α-
DC-SIGN [clone AZN-D1 (Geijtenbeek et al., 2000b)],α-dendritic
cell immunoreceptor [DCIR, clone 111F8.04 (Dendritics)], and
α-mannose receptor [MR, clone 19.2 (BD Bioscience)]. Stain-
ings were performed using 5µg/ml of primary antibody and
5µg/ml of AlexaFluor 488 F(ab′)2 fragment of goat anti-mouse
IgG (Invitrogen) as secondary antibody.
PSA AND Sp1
PSA was purified from B. fragilis as previously described (Cobb
et al., 2004). Labeling was performed by oxidation of 20% of
the galactofuranose side chain sugar. AlexaFluor 488 (AF488) was
added via the aldehyde group (Cobb et al., 2004). Sp1 was prepared
as described previously (Tzianabos et al., 2000b).
CELLS
Raji and Raji-DC-SIGN cells (Geijtenbeek et al., 2000a) were
cultured in RPMI1640 (Invitrogen) supplemented with 10%
FBS (BioWhittaker), 1000 U/ml penicillin/streptomycin (Lonza),
and 2 mM glutamine (Lonza). Monocytes were isolated from
PBMCs from buffy coats of healthy donors (Sanquin) by a lym-
phoprep gradient (Axis-Shield) and a subsequent percoll gradi-
ent centrifugation (Amersham). DCs were generated by cultur-
ing purified monocytes in RPMI1640 supplemented with 10%
FBS, 1000 U/ml penicillin/streptomycin, and 2 mM glutamine in
combination with IL-4 (262.5 U/ml; Biosource) and GM-CSF
(112.5 U/ml; Biosource) for 4–7 days. CD4+ T cells were isolated
from the PBL fraction of buffy coats of healthy donors via nega-
tive selection using MACS beads (Milteny Biotec) according to the
manufacturer’s instructions.
BINDING/INTERNALIZATION ASSAYS
PSA-AF488 was incubated with DCs for 3 h at 37˚C at the indicated
concentrations in PBS containing calcium. For blocking experi-
ments, 30µg/ml PSA-AF488 was incubated with DCs for 45 min
at 37˚C in the presence of blocking agents and monitored by flow
cytometry (FACScan, BD Biosciences). All flow cytometric analy-
sis was performed with Flowjo software (Tree star). DC-SIGN
expressing Raji cells were incubated with the indicated concentra-
tions of PSA-AF488 for 3 h at 37˚C. Unbound PSA was washed
away and the amount of bound/internalized PSA was measured
by flow cytometry. CLRs were blocked with a final concentration
of 20µg/ml of CLR-specific blocking antibodies, 50 mM mono-
saccharides [α-N -acetyl-d-glucosamine, α-l-Fucose, d-galactose,
d-glucose, N -acetyl-d-glucosamine (Sigma Aldrich)], 25µg/ml
mannan (Sigma Aldrich), 25µg/ml Laminarin (Sigma Aldrich),
25µg/ml mannose-BSA (Sigma Aldrich), or 10 mM EGTA for
30 min at 37˚C prior to the PSA binding assay.
INTERNALIZATION ASSAY
PSA-AF488 was incubated with DCs for 3 h at 37˚C at the indicated
concentrations in PBS buffer containing calcium. As a positive and
negative control, cells were incubated with a targeting antibody
against DC-SIGN (AZN-D1) for 3 h at either 37 or 4˚C respectively.
Cells were washed in ice-cold PBS, fixated in 4% paraformalde-
hyde (Electron Microscopy Sciences), and measured by imaging
flow cytometry (AMNIS Inc.) as previously described (García-
Vallejo et al., 2012). Cells that have internalized antigen typically
have positive internalization scores while cells that show the anti-
gen still on the membrane have negative scores. Cells with scores
around 0 have similar amounts of antigen on the membrane and
in intracellular compartments.
DC-SIGN-Fc BINDING ASSAY
Ninety six-well flat-bottomed ELISA plates (Maxisorp, Nunc) were
coated with 10µg/ml or indicated concentrations of unlabeled
PSA or Sp1 in PBS or LewisX-polyacrylamide conjugate (PAA,
Lectinity) in coating buffer (50 mM Na2CO3, pH 9.7) overnight
at room temperature. DC-SIGN-Fc binding was measured as
previously described (García-Vallejo et al., 2012).
T CELL PROLIFERATION ASSAY
Irradiated (3500 rad) DCs were pre-incubated in the presence or
absence of 20µg/ml AZN-D1 for 30 min at 37˚C. PSA was added
at a concentration of 30µg/ml and incubated for 3 h at 37˚C.
Unbound PSA and AZN-D1 were washed away and DCs were
incubated with autologous CD4+ T cells for 6 days at a ratio of 1:10
in combination with 100µM of the NO substrate glyco-SNAP-2
(Calbiochem). PSA binding and uptake and the blocking effect of
α-DC-SIGN were monitored by simultaneously incubation of DCs
with PSA-AF488 and measured by flow cytometry. Proliferation
was measured using [3H]-thymidine incorporation (1µCi/well;
Amersham Bioscience) for 16 h. Cells were harvested onto filters
and the [3H]-thymidine incorporation was measured with the use
of a beta counter (Perkin Elmer).
STATISTICAL ANALYSIS
P values were calculated with a Student’s t -test. P values< 0.05
were considered to be significant.
RESULTS
THE INTERACTION OF PSA WITH DCs IS CARBOHYDRATE-DEPENDENT
Although the unique feature of PSA to activate specific CD4+ T
cell responses in humans has long been demonstrated (Tzianabos
et al., 2000b), the molecular mechanisms leading to recognition
and internalization, a crucial step in the processing and load-
ing of PSA onto MHC class II, are still unclear. Since PSA is
a complex carbohydrate and CLRs on DCs are involved in the
recognition of glycans, CLRs appear to be the prime candidates
for the recognition of PSA by APCs. In addition, several CLRs
are antigen-uptake receptors for presentation on MHC class II
or MHC class I (Sancho and Reis e Sousa, 2012). Therefore, we
first analyzed whether DCs, known to express a wide variety of
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CLRs, were able to bind PSA. Our results show that human DCs
efficiently bound PSA in a dose-dependent manner (Figure 1A).
Although DCs exposed to PSA for a prolonged period of time
at 37˚C are expected to internalize any bound material, we could
not deduce this from classical flow cytometry data. We therefore
measured PSA-incubated DCs using imaging flow cytometry. As
a positive and negative control we treated DCs with a mono-
clonal antibody against DC-SIGN, known to induce DC-SIGN
internalization (Engering et al., 2002a), at 37 or 4˚C, respec-
tively. Triggering of DC-SIGN induced internalization only at
37˚C. The signal corresponding to PSA perfectly overlapped with
that of the positive control, indicating that PSA was efficiently
internalized under these conditions (Figure 1B). To determine
whether CLRs play a role in the binding/internalization of PSA
we analyzed binding/internalization by flow cytometry in the
presence of EGTA, a Ca2+ chelator. Results indicate that PSA
binding/internalization by DCs was indeed Ca2+-dependent, a
typical characteristic of CLRs (Figure 1C). In order to elucidate
the identity of the CLR(s) involved in the recognition of PSA,
we incubated DCs with PSA in the presence of different mono
and polysaccharides as competitive inhibitors for CLRs. Bind-
ing/internalization of PSA could be blocked in the presence of
fucose and mannan (Figure 1D), in concentrations previously
shown to block DC-SIGN-dependent ligand binding (Curtis et al.,
1992). In addition, high concentrations of glucose and N -acetyl-
d-glucosamine (GlcNAc) could also block binding/internalization
of PSA, although to a lesser extent (Curtis et al., 1992; Lee et al.,
2011). Altogether these results indicate the involvement of a
mannose/fucose-specific CLR, such as DC-SIGN or MR. Other
mono and polysaccharides, like laminarin (a dectin-1-specific gly-
can) and GalNAc (a macrophage galactose-type lectin-specific
sugar) did not alter PSA binding/internalization (Figure 1D).
Also, Mannose-BSA (a MR-specific ligand) did not inhibit PSA
binding/internalization (Figure 1D), suggesting that MR is not
involved in the recognition of PSA by DCs. Therefore, we con-
cluded that the CLR DC-SIGN is a likely PSA receptor on
DCs.
PSA INTERACTS WITH DC-SIGN
To examine whether DC-SIGN directly binds to PSA, we used
a DC-SIGN-Fc chimeric protein consisting of the extracellu-
lar domains, including the carbohydrate recognition domain of
DC-SIGN fused to the human IgG1 Fc tail. We compared DC-
SIGN-binding to PSA to the well-known DC-SIGN ligand LewisX.
Concentration-dependent binding of DC-SIGN-Fc to both PSA
and LewisX was observed and the interaction appeared to be Ca2+-
dependent, since it could be blocked by the addition of EGTA
(Figure 2A). To confirm the binding of PSA at the cellular level, we
used a Raji cell line transduced with DC-SIGN (Geijtenbeek et al.,
2000a). Raji-DC-SIGN cells expressed high levels of DC-SIGN,
which was absent on the parental Raji cells (Figure 2B). PSA bound
the Raji-DC-SIGN cells in a concentration-dependent manner,
which could be blocked by EGTA to the level of the parental Raji
cells (Figure 2C). Several ZPSs have similar functional character-
istics as PSA, including the induction of CD4+ T cell proliferation
and the development of peritoneal abscesses (Velez et al., 2009).
One of these ZPSs is Sp1, the capsular polysaccharide from type
FIGURE 1 | PSA-binding/internalization by DCs can be blocked through
Ca2+ chelation or by competition with glycans. (A) PSA is recognized by
DCs. PSA-AF488 binding was evaluated by flow cytometry after 3 h of
incubation at 37˚C. The line represents the average median fluorescence
intensity (MFI) of the two donors. (B) PSA is internalized by DCs. Incubation
of PSA-AF488 with DCs for 3 h at 37˚C resulted in an efficient internalization
of PSA. DCs incubated with a DC-SIGN-targeting antibody for 30 min at
either 4 or 37˚C were used as negative and positive controls, respectively.
(C) PSA-binding/internalization is blocked by the addition of EGTA.
Binding/internalization of PSA-AF488 by DCs was measured by flow
cytometry in the presence of the Ca2+ chelator EGTA. Binding is shown
relative to the autofluorescence of DCs. (D) PSA-binding/internalization is
blocked by competition with mono and polysaccharides. GalNAc,
α-N -acetyl-d-glucosamine; Fuc, α-l-fucose; Gal, d-galactose; Glc, d-glucose;
GlcNAc, N -acetyl-d-glucosamine. Binding/internalization of PSA-AF488 by
DCs was measured by flow cytometry after pre-incubation with the various
mono and polysaccharides. Data is shown relative to DCs incubated with
PSA in the absence of inhibitors. Data is shown as mean±SD of a
representative experiment out of six.
1 Streptococcus pneumoniae. Although the biological properties of
Sp1 mimic those of PSA, Sp1 was not recognized by DC-SIGN
(Figure 2D), suggesting that DC-SIGN is a PSA-specific receptor
and not a general binding partner for all ZPSs.
BLOCKING DC-SIGN FUNCTION INHIBITS PSA-INDUCED T CELL
PROLIFERATION
Since we identified DC-SIGN as a specific PSA receptor, we con-
tinued our research to determine the contribution of DC-SIGN in
the presentation of PSA by DCs to CD4+ T cells. DCs express dif-
ferent CLRs, such as DCIR and MR, that share overlapping glycan
specificity with DC-SIGN (Figure 3A). To rule out a possible
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FIGURE 2 | PSA binds to DC-SIGN. (A) Binding of PSA to DC-SIGN-Fc
was measured using a DC-SIGN-binding assay. Binding of DC-SIGN-Fc to
LewisX-PAA served as a positive control. (B) Expression of DC-SIGN on
parental Raji and Raji-DC-SIGN cells as measured by flow cytometry. Black
line represents isotype control and red line indicates DC-SIGN expression.
(C) PSA-binding/internalization via cellular DC-SIGN. Binding/internalization
of different concentrations of PSA-AF488 was measured by flow cytometry
after 3 h incubation at 37˚C. CLR-specific binding was blocked by the
addition of EGTA. (D) Sp1 is unable to bind the DC-SIGN-Fc construct. PSA
and Sp1 were coated to an ELISA plate and DC-SIGN-binding was
measured using a DC-SIGN-Fc binding assay. Data is shown relative to the
non-coating control. Data is shown as mean±SD of a representative
experiment out of three.
involvement of these CLRs in the recognition of PSA, we tested the
ability of different CLR blocking antibodies to inhibit PSA binding.
Based on titration of the DC-SIGN antibody in previously pub-
lished experiments (Geijtenbeek et al., 2000b), a concentration of
20µg/ml blocking antibody was used. We observed that only the
DC-SIGN blocking antibody decreased binding/internalization
significantly, which was not further enhanced in combination with
anti-MR or DCIR blocking antibodies (Figure 3B). These data
confirmed DC-SIGN as the main receptor on DCs for the recog-
nition of PSA. DC-SIGN functions as internalization receptor
that mediates antigen routing to MHC class II loading com-
partments (Engering et al., 2002a). To assess the contribution of
DC-SIGN in the MHC class II presentation of PSA to T cells, DCs
FIGURE 3 | Inhibition of DC-SIGN function decreases PSA
internalization and PSA-inducedT cell proliferation. (A) Expression of
DC-SIGN, MR, and DCIR on DCs as measured by flow cytometry. Black line
represents isotype control, blue line indicates DC-SIGN expression, green
line indicates DCIR expression, and red line represents MR expression. (B)
PSA-binding/internalization by DCs is only blocked in the presence of a
DC-SIGN blocking antibody. Data is shown relative to DCs incubated with
PSA in the absence of inhibitors. (C) DC-SIGN blocking antibodies decrease
PSA-binding/internalization by DCs. Binding/internalization of PSA-AF488 by
irradiated DCs was measured by flow cytometry after 3 h incubation at
37˚C. (D) Inhibition of DC-SIGN function decreases PSA-specific T cell
proliferation. Irradiated DCs were pre-incubated with a DC-SIGN blocking
antibody and subsequently incubated with PSA for 3 h at 37˚C, extensively
washed, and incubated with autologous CD4+ T cells in the presence of the
NO donor glyco-SNAP-2. T cell proliferation was measured by
[3H]-thymidine incorporation. Data is shown as mean±SD of triplicates
(*p<0.05 **p<0.01). All experiments were performed three times with
independent donors, one representative experiment is shown.
were pulsed with PSA in the presence or absence of DC-SIGN
blocking antibodies for 3 h, after which unbound PSA was washed
away. PSA binding/uptake by DCs was clearly decreased in the
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presence of α-DC-SIGN (Figure 3C). The observed increase in
CD4+ T cell proliferation by PSA-incubated DCs confirms the
presence of PSA-specific T cells in blood (Figure 3D). Further-
more, PSA-specific T cell proliferation was completely inhibited
in the presence of blocking antibodies to DC-SIGN (Figure 3D);
demonstrating a DC-SIGN-dependent role in the uptake and pro-
cessing of PSA for MHC class II presentation and subsequent T
cell activation.
In conclusion, we have shown that DC-SIGN plays a crucial
role in the binding and internalization of the T cell activating
ZPSs PSA by human DCs. In addition, inhibiting DC-SIGN func-
tion decreases MHC class II presentation and subsequent T cell
activation.
DISCUSSION
PSA is one of the ZPSs that can be presented in MHC class II for
recognition by CD4+ T cells (Tzianabos et al., 2000b). Although
internalization and NO-dependent processing of PSA is required
for optimal presentation in MHC class II (Cobb et al., 2004; Duan
et al., 2008), the identity of the receptor mediating binding and
internalization of PSA has remained elusive. DC express several
CLRs, specialized in glycan recognition and routing of internal-
ized ligands to MHC class II or MHC class I loading compartments
(Sancho and Reis e Sousa, 2012). We therefore hypothesized that a
CLR might be involved and in this study we identified DC-SIGN as
crucial receptor for PSA internalization and MHC-II presentation
by human DCs.
Zwitterionic polysaccharides are generally composed of repeat-
ing oligosaccharide units. These oligosaccharide units are different
for PSA and Sp1, explaining why PSA interacted with the purified
DC-SIGN-Fc molecule, while the binding of Sp1 to DC-SIGN-Fc
could not be detected. The oligosaccharide structure in PSA is
[→3)-α-d-AAT Galp-(1→4)-[β-d-Galf-(1→3)] α-d-GalpNAc-
(1→3)-[4,6-pyruvate]-β-d-Galp-(1→] (Tzianabos et al., 1992),
while Sp1 is composed of the following oligosaccharide
structure: [→3)-α-2,4-dideoxy-4-amino-d-FucNAc-(1→4)-α-d-
GalAp-(1→3)-α-d-GalAp-(1→] (Velez et al., 2009). DC-SIGN
has specificity for mannose- and fucose-containing glycan struc-
tures, and can therefore interact with a wide variety of pathogens
(Appelmelk et al., 2003). However, both fucose and mannose gly-
cans are not present in the PSA oligosaccharide. Since the β-d-Galf
glycan forms a side group in PSA, it is the most easily accessible
carbohydrate for the binding to DC-SIGN. Sp1 from S. pneu-
monia, lacks this side group, potentially explaining the inability
of DC-SIGN to bind to Sp1. It goes beyond the scope of this
study to determine the exact glycan moiety in PSA that interacts
with DC-SIGN. Together, our results indicate that DC-SIGN is
a PSA-specific receptor and not a general binding partner for all
ZPSs.
Next to the DC-SIGN-mediated PSA binding at the molecular
level, we show an enhanced binding of PSA to DC-SIGN express-
ing Raji cells over the parental cell line. Raji cells are frequently
used as model for PSA internalization and presentation in MHC
class II (Kalka-Moll et al., 2002; Cobb et al., 2004; Cobb and
Kasper, 2008; Duan et al., 2008; Ryan et al., 2011). In our assays
PSA internalization was also detectable in the parental cell line,
however this could only be observed when cells were incubated
with high concentrations of PSA. DC-SIGN expression in Raji cells
clearly increased PSA uptake and blocking DC-SIGN function on
DCs significantly reduced PSA internalization and MHC-II pre-
sentation, while inhibition of other CLRs with overlapping glycan
specificity, such as MR and DCIR, had no effect. These data indi-
cate a crucial role of DC-SIGN in the binding and internalization
of PSA by DCs.
DC-SIGN-binding ligands are quickly internalized and routed
to endosomes and lysosomes (Engering et al., 2002a). Although
the presence of DC-SIGN-binding glycans on protein antigens is
necessary for the DC-SIGN-mediated routing to MHC class II
loading compartments, it is a protein-derived peptide that is pre-
sented in MHC class II (Aarnoudse et al., 2008). Therefore, PSA
is the first glycan structure internalized in a DC-SIGN-dependent
manner that is presented solely onto MHC class II in the absence
of a protein.
The presentation of PSA in MHC class II has previously been
shown by the activation of human CD4+ T cell responses in vitro
using PBMCs as APCs (Tzianabos et al., 2000b; Velez et al., 2009).
Capture of PSA in this setting could be mediated by the small
DC-SIGN+ subpopulation present in PBMCs (Engering et al.,
2002b) or by the non-specific uptake typically observed in long
term in vitro cell cultures using high PSA doses. DCs, on the other
hand, are more likely candidates for the encounter of PSA under
physiological conditions. We here demonstrate the ability of DCs
to present DC-SIGN-internalized PSA in MHC class II, result-
ing in the activation of autologous CD4+ T cell responses. The
induction of PSA-specific T cell proliferation could already be
induced after short incubation times using relatively low concen-
trations of PSA, more closely mimicking the physiological setting.
Activation of PSA-specific CD4+ T cells requires not only inter-
nalization of PSA, but also NO-dependent PSA processing and
loading onto MHC class II (Cobb et al., 2004). Therefore, PSA
loaded DCs were co-cultured with autologous CD4+ T cells in the
presence of a NO donor (glyco-SNAP-2), to ensure the availabil-
ity of sufficient NO to cleave the PSA. The use of glyco-SNAP-2
was necessary, since compared to DCs present in vivo, in vitro cul-
tured monocyte-derived DCs hardly produce NO (Nishioka et al.,
2003).
Besides being an internalization receptor, DC-SIGN has also
been described to modify TLR signaling. Geijtenbeek et al. (2003)
showed that binding of the mannosylated ligand ManLAM to DC-
SIGN results in an increased IL-10 secretion by LPS-stimulated
DCs. Surprisingly, the effect of DC-SIGN stimulation on TLR-
induced cytokine responses is dependent on the interacting glycan.
Whereas both mannose- and fucose-expressing ligands increase
the IL-10 secretion by LPS-stimulated DCs, the effect on IL-
12 and IL-6 secretion is different, whereby fucose-expressing
ligands decrease the LPS-induced IL-12 and IL-6 production,
while mannose-expressing ligands increase the LPS-induced IL-
12 and IL-6 secretion (Gringhuis et al., 2009). The effects of
PSA-mediated DC-SIGN stimulation still needs to be further
investigated.
PSA-induced T cell proliferation has been reported in mice
as well (Tzianabos and Kasper, 2002). In the murine genome
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eight different homologs of DC-SIGN are present (SIGNR1-8).
The internalization capacity of these lectins has been investigated
only for SIGNR1, SIGNR3, and SIGNR5, whereby SIGNR1 and
SIGNR3 were reported to function as antigen-uptake receptors,
whereas this was not the case for SIGNR5 (Takahara et al., 2004;
Powlesland et al., 2006). SIGNR1 has been identified on lam-
ina propria DCs in the murine intestine, where it mediates the
induction of oral tolerance through the generation of Tr1 cells
(Zhou et al., 2010). PSA derived from B. fragilis, a commensal bac-
terium in the gut, has also been described to induce regulatory
T cells (Round and Mazmanian, 2010). Preliminary results from
our laboratory indicate SIGNR1 as PSA-binding receptor (data
not shown); however we cannot exclude the involvement of other
receptors in the binding and internalization of PSA in mice in vivo.
In conclusion, we have shown that DC-SIGN plays a crucial
role in the binding and internalization of the T cell activating
ZPS PSA by human DCs. In addition, inhibiting DC-SIGN func-
tion decreases MHC class II presentation and subsequent T cell
activation. These data indicate that DC-SIGN behaves as an
antigen-uptake receptor for PSA, resulting in loading onto MHC
class II molecules and the activation of PSA-specific CD4+ T cell
responses.
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